E-mail: alexandra.todescatto@gmail.com Declared conflict of interest of all authors: none Associate editor: Ulysses Ribeiro 09 1 2026 2025 62 487686 e25013 26 1 2025 04 8 2025 09 01 2026 10 01 2026 17 01 2026 https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License ABSTRACT Background: The approval of new therapies has led to an increasing trend toward the use of various combinations of medications in Crohn’s disease (CD) management.
1
—
—